Torcap Tablets 200mg

Torcap Tablets 200mg, manufactured by AstraZeneca, contains Capivasertib (YJ code: 4291082F2024, standard: 200mg x 1 tablet). This selective pan-AKT kinase inhibitor interferes with the PI3K/AKT/mTOR signaling pathway, which is critical for cancer cell growth and survival. It is being developed as a potential treatment for various solid and hematological malignancies, often in combination with other anti-cancer agents.